Celularity, Inc. (CELU)
0.9777
-0.07
(-6.89%)
USD |
NASDAQ |
Oct 23, 16:00
0.9606
-0.02
(-1.75%)
After-Hours: 20:00
Celularity Enterprise Value : 97.88M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 97.88M |
| October 22, 2026 | 99.99M |
| October 21, 2026 | 99.12M |
| October 20, 2026 | 106.14M |
| October 19, 2026 | 103.22M |
| October 16, 2026 | 105.85M |
| October 15, 2026 | 108.19M |
| October 14, 2026 | 107.61M |
| October 13, 2026 | 110.83M |
| October 12, 2026 | 112.29M |
| October 09, 2026 | 114.93M |
| October 08, 2026 | 112.00M |
| October 07, 2026 | 112.29M |
| October 06, 2026 | 115.52M |
| October 05, 2026 | 119.32M |
| October 02, 2026 | 116.10M |
| October 01, 2026 | 109.66M |
| September 30, 2026 | 108.78M |
| September 29, 2026 | 109.37M |
| September 28, 2026 | 110.24M |
| September 25, 2026 | 109.66M |
| September 24, 2026 | 107.90M |
| September 23, 2026 | 102.92M |
| September 22, 2026 | 103.80M |
| September 21, 2026 | 105.56M |
| Date | Value |
|---|---|
| September 18, 2026 | 107.61M |
| September 17, 2026 | 106.44M |
| September 16, 2026 | 107.02M |
| September 15, 2026 | 105.56M |
| September 14, 2026 | 110.24M |
| September 11, 2026 | 110.54M |
| September 10, 2026 | 111.27M |
| September 09, 2026 | 111.42M |
| September 08, 2026 | 114.34M |
| September 04, 2026 | 118.44M |
| September 03, 2026 | 122.84M |
| September 02, 2026 | 123.71M |
| September 01, 2026 | 124.30M |
| August 31, 2026 | 123.42M |
| August 28, 2026 | 115.52M |
| August 27, 2026 | 130.74M |
| August 26, 2026 | 95.03M |
| August 25, 2026 | 92.70M |
| August 24, 2026 | 91.94M |
| August 21, 2026 | 92.68M |
| August 20, 2026 | 91.71M |
| August 19, 2026 | 92.03M |
| August 18, 2026 | 90.82M |
| August 17, 2026 | 89.63M |
| August 14, 2026 | 89.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -63.02M |
| Exicure, Inc. | 4.976M |
| Century Therapeutics, Inc. | 182.55M |
| Absci Corp. | 1.378B |
| Cardio Diagnostics Holdings, Inc. | -0.2154M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.546M |
| Revenue (Quarterly) | 5.432M |
| Total Expenses (Quarterly) | 4.886M |
| EPS Diluted (Quarterly) | 0.0186 |
| Gross Profit Margin (Quarterly) | 28.48% |
| Profit Margin (Quarterly) | 10.05% |
| Earnings Yield | -172.1% |
| Normalized Earnings Yield | -166.65 |